Levothyroxine Sodium
Brand name: Levothyroxine Sodium
Rank #44 of 500 drugs by total cost
$435.3M
Total Cost
20,209,418
Total Claims
$435.3M
Total Cost
167,050
Prescribers
$22
Cost per Claim
4,995,485
Beneficiaries
46,809,828
30-Day Fills
$2,606
Avg Cost/Provider
121
Avg Claims/Provider
About Levothyroxine Sodium
Levothyroxine Sodium (sold as Levothyroxine Sodium) was prescribed 20,209,418 times by 167,050 Medicare Part D providers in 2023, costing the program $435.3M. At $22 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 41 | Acalabrutinib Maleate (Calquence) | $457.0M | 31,890 |
| 42 | Atorvastatin Calcium (Atorvastatin Calcium) | $444.6M | 30,263,929 |
| 43 | Osimertinib Mesylate (Tagrisso) | $436.5M | 25,273 |
| 44 | Levothyroxine Sodium (Levothyroxine Sodium) | $435.3M | 20,209,418 |
| 45 | Deutetrabenazine (Austedo) | $404.1M | 60,532 |
| 46 | Linagliptin (Tradjenta) | $403.8M | 519,439 |
| 47 | Macitentan (Opsumit) | $394.6M | 30,889 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology